UBC researcher Dr. Josef Penninger has found a potential drug therapy that blocks the cellular door used by the COVID-19 virus to infect its hosts. Experts say the research is 'promising' but human testing is needed first.
from CBC | Health News https://ift.tt/39GnHFr
Aucun commentaire:
Enregistrer un commentaire